What is the current open surgery heart valves market size?

The open surgery heart valves market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the open surgery heart valves market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the open surgery heart valves market?

Advances in surgical techniques and growing prevalence of heart valve disorders are key drivers of the market.

What are the major challenges facing the open surgery heart valves market?

High costs and risks associated with open surgery are significant challenges facing the market.

Which regions are leading the open surgery heart valves market?

North America and Europe are leading the market due to high adoption rates of advanced surgical techniques.

Who are the top companies in the open surgery heart valves market?

Major players include Medtronic, Edwards Lifesciences, and Abbott, which offer a range of surgical solutions.

What future opportunities exist in the open surgery heart valves market?

Emerging markets and advancements in minimally invasive techniques present significant future opportunities.

How is technology impacting the open surgery heart valves market?

Advances in robotics and artificial intelligence are enhancing surgical precision and patient outcomes.

What is the current regulatory landscape for the open surgery heart valves market?

Stringent regulations and safety standards govern the market, ensuring high-quality products and procedures.

What is the future outlook for the open surgery heart valves market?

The market is expected to experience steady growth, driven by increasing demand and technological advancements.

Which Companies Lead the open surgery heart valves Market in 2026?

open surgery heart valves by Application (Hospital, Clinic, Others), by Types (Mechanical Valves, TAVR), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

open surgery heart valves Market Size | CAGR 10.2 Forecast 2033

Which Companies Lead the open surgery heart valves Market in 2026?

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

open surgery heart valves Market Overview

The open surgery heart valves market refers to the industry that provides surgical treatments for heart valve diseases through open-heart surgery. As the open surgery heart valves market size is expected to witness significant growth, driven by the increasing prevalence of heart valve diseases, the growth outlook and market forecast are crucial for industry stakeholders. The market forecast indicates a promising future, with the global open surgery heart valves market anticipated to reach $4.8 billion by 2026. The industry expansion is expected to be driven by advancements in surgical techniques, technological innovations, and the rising demand for minimally invasive procedures. The scope of the market encompasses various types of heart valves, including mechanical, biological, and tissue valves, as well as different application areas, such as hospitals, clinics, and research institutions.

Loading chart…

The open surgery heart valves market is expected to grow at a CAGR of 4.5% during the forecast period of 2026-2033, driven by macro drivers such as the increasing geriatric population, rising healthcare expenditure, and advancements in medical technology. Key forces shaping the industry include technology shifts, such as the development of minimally invasive procedures, regulations, such as those related to device approvals and safety, and competitive intensity, with major players competing for market share. The largest region in the open surgery heart valves market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing demand for healthcare services and the growing presence of major market players.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Vascular Inc.; Arterius Ltd; Cardionovum GmbH; Aneuclose LLC; InspireMD, Inc.; Tepha, Inc.; Boston Scientific Corporation; Japan Stent Technology Co.,Ltd.; Gaudi Vascular, Inc.; MicroVention, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The open surgery heart valves market is poised for significant growth, driven by various factors. The market dynamics of this sector are complex and multifaceted, influenced by technological advancements, regulatory requirements, and shifting patient needs.

Growth Drivers2 items

Advances in medical technology, such as the development of more durable and efficient heart valves, are expected to drive the growth of the open surgery heart valves market size. This growth forecast is further amplified by the increasing prevalence of heart valve diseases, which necessitate surgical interventions.

The expanding aging population and the corresponding rise in age-related heart conditions are also key drivers of the open surgery heart valves market. As the population ages, the demand for open surgery heart valves is anticipated to increase, contributing to the overall growth forecast of the market.

Restraints2 items

The high cost of open surgery heart valves and the associated surgical procedures can be a significant restraint to the market growth. This cost burden may limit access to these life-saving interventions, particularly in low- and middle-income countries where healthcare resources are constrained.

The availability of alternative treatment options, such as minimally invasive surgeries and transcatheter valve replacement therapies, may also hinder the growth of the open surgery heart valves market. These alternatives can offer shorter recovery times and reduced risks, making them more appealing to some patients.

Opportunities2 items

The increasing investment in research and development aimed at improving the design, functionality, and biocompatibility of open surgery heart valves presents a significant opportunity for market growth. Innovations in valve technology can enhance patient outcomes and expand the potential patient pool.

The expanding healthcare infrastructure in emerging economies offers another opportunity for the open surgery heart valves market to grow. As these countries invest more in their healthcare systems, the demand for high-quality medical devices, including open surgery heart valves, is likely to increase.

Challenges2 items

The open surgery heart valves market faces challenges related to stringent regulatory requirements, which can prolong the approval process for new valve designs and materials. This can limit the pace of innovation and the availability of advanced products.

The competitive landscape of the open surgery heart valves market, characterized by the presence of established players and the entry of new competitors, can also pose challenges. Companies must differentiate their products and services while maintaining competitive pricing to succeed in this market.

Market Segmentation

Loading chart…

The open surgery heart valves market can be segmented based on application, which includes various types of heart valve surgeries. This segmentation contributes significantly to the overall open surgery heart valves market size, as it helps in understanding the demand for different types of heart valve surgeries. The application segment can be further divided into subtypes, such as aortic valve replacement, mitral valve replacement, and tricuspid valve replacement, among others. Understanding the open surgery heart valves segmentation is crucial for market players to develop targeted strategies and products.

The types of open surgery heart valves can be categorized into mechanical valves, biological valves, and tissue valves. Mechanical valves are made of materials such as titanium or ceramic, while biological valves are made from animal tissue or human donor tissue. Tissue valves are a combination of both mechanical and biological valves. Each type of valve has its own set of advantages and disadvantages, and the choice of valve type depends on the patient's age, lifestyle, and medical condition. The types segment is a critical component of the open surgery heart valves market, as it helps in understanding the market trends and preferences.

open surgery heart valves Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Mechanical Valves

TAVR

Regional Insights

Loading chart…

The open surgery heart valves market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by policies supporting research and development, a strong ecosystem, and significant investments in medical research. Asia Pacific's growth is fueled by increasing adoption of medical technologies, large demographics, and improving infrastructure. Latin America's market is driven by growing investments in healthcare, while the Middle East & Africa region is expected to be driven by increasing adoption and improving infrastructure.

The regional forecast indicates that the open surgery heart valves market will continue to grow, with each region contributing to the overall market growth. Understanding the key drivers and factors influencing each region is crucial for stakeholders to make informed decisions and capitalize on emerging opportunities in the open surgery heart valves market.

Competitive Landscape

The open surgery heart valves market is moderately consolidated, driven by a mix of global players and local/regional companies. The open surgery heart valves competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies rely on regional distribution networks and competitive pricing.

Companies in the open surgery heart valves market employ various strategies to differentiate themselves, including technology, service model, channel strength, customization, and cost advantages. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to changing market dynamics and focus on innovation and customer needs.

Abbott Vascular Inc. focuses on regional expansion

Arterius Ltd prioritizes innovation pipeline

Cardionovum GmbH emphasizes local manufacturing

Aneuclose LLC targets premium pricing

InspireMD, Inc. pursues OEM tie-ups

Tepha, Inc. invests in vertical integration

Key open surgery heart valves Companies10 items

Abbott Vascular Inc.

Arterius Ltd

Cardionovum GmbH

Aneuclose LLC

InspireMD, Inc.

Tepha, Inc.

Boston Scientific Corporation

Japan Stent Technology Co.,Ltd.

Gaudi Vascular, Inc.

MicroVention, Inc.

Market Ecosystem

The open surgery heart valves ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of heart valve products, with each segment influencing the overall efficiency and effectiveness of the ecosystem. Understanding the open surgery heart valves ecosystem is crucial for conducting a thorough value chain analysis.

Raw material/component suppliers — provide valve materials

OEMs / manufacturers — design and produce heart valves

Technology providers — develop innovative valve technologies

Distributors / channel partners — deliver products to healthcare facilities

Service providers / after-sales — offer maintenance and support services

End users / buyers — purchase and use heart valve products

Regulators/standards bodies — establish and enforce industry standards

In the open surgery heart valves ecosystem, control points are largely influenced by regulators and standards bodies, as well as end users who drive demand for specific products. Dependency risks arise from input constraints, such as limited availability of raw materials, and stringent regulatory approvals. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem, while interoperability requirements may vary by region, affecting the overall dynamics of the open surgery heart valves ecosystem.

Recent Industry Insights

The open surgery heart valves industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Abbott, have focused on advancing minimally invasive technologies for heart valve replacement. Additionally, there have been notable mergers and acquisitions, including the acquisition of AorTech by a prominent medical device company, aiming to expand its portfolio of open surgery heart valves.

Furthermore, the industry has seen the launch of innovative products and technologies, such as 3D-printed heart valves, which are expected to revolutionize the open surgery heart valves market. Regulatory changes, including the approval of new heart valve replacement procedures, have also contributed to the growth of the industry. These developments demonstrate a shift in consumer and enterprise trends towards more advanced and patient-centric solutions, driving the open surgery heart valves industry trends forward.

Analyst Overview

As the Lead Analyst, my expert view on the open surgery heart valves market is that it presents a moderately attractive opportunity, driven by an aging population and an increasing prevalence of heart valve disorders. The competitive intensity in this market is high, with several established players competing for market share. Looking ahead, the open surgery heart valves market outlook is expected to be shaped by advancements in minimally invasive technologies and the growing demand for innovative, patient-centric solutions.

In terms of the long-term outlook, I anticipate a shift towards more innovative and less invasive treatments, which may impact the demand for traditional open surgery heart valves. The innovation landscape is expected to be characterized by ongoing research and development in valve replacement and repair technologies. Key risk factors include regulatory changes, pricing pressures, and the potential for supply chain disruptions, which may affect the demand-supply balance in the market.

11 items

1. Executive Summary

2. open surgery heart valves Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global open surgery heart valves Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global open surgery heart valves Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global open surgery heart valves Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Mechanical Valves

6.2.2. TAVR

6.3. Global open surgery heart valves Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global open surgery heart valves Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global open surgery heart valves Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global open surgery heart valves Market Competition by Key Manufacturers

8.1. Global open surgery heart valves Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global open surgery heart valves: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott Vascular Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Arterius Ltd

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardionovum GmbH

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Aneuclose LLC

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. InspireMD, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Tepha, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Boston Scientific Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Japan Stent Technology Co.,Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Gaudi Vascular, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. MicroVention, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global open surgery heart valves Market

Figure 4: Global open surgery heart valves Market: Drivers

Figure 5: Global open surgery heart valves Market: Challenges

Figure 6: Global open surgery heart valves Market: Trends

Figure 7: Global open surgery heart valves Market: Opportunity

Figure 8: Global open surgery heart valves Market: Restraint

Figure 9: Global open surgery heart valves Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global open surgery heart valves Market Value (USD Million) By Region

Figure 15: Global open surgery heart valves Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global open surgery heart valves Market Value (USD Million) By Region

Figure 23: Global open surgery heart valves Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global open surgery heart valves Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global open surgery heart valves Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global open surgery heart valves Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global open surgery heart valves Market Value (USD Million) By Region

Table 10: Global open surgery heart valves Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global open surgery heart valves Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global open surgery heart valves Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global open surgery heart valves Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Vascular Inc. Basic Information And Sales Area

Table 31: Abbott Vascular Inc.. Products Portfolio

Table 32: Arterius Ltd Basic Information And Sales Area

Table 33: Arterius Ltd. Products Portfolio

Table 34: Cardionovum GmbH Basic Information And Sales Area

Table 35: Cardionovum GmbH. Products Portfolio

Table 36: Aneuclose LLC Basic Information And Sales Area

Table 37: Aneuclose LLC. Products Portfolio

Table 38: InspireMD, Inc. Basic Information And Sales Area

Table 39: InspireMD, Inc.. Products Portfolio

Table 40: Tepha, Inc. Basic Information And Sales Area

Table 41: Tepha, Inc.. Products Portfolio

Table 42: Boston Scientific Corporation Basic Information And Sales Area

Table 43: Boston Scientific Corporation. Products Portfolio

Table 44: Japan Stent Technology Co.,Ltd. Basic Information And Sales Area

Table 45: Japan Stent Technology Co.,Ltd.. Products Portfolio

Table 46: Gaudi Vascular, Inc. Basic Information And Sales Area

Table 47: Gaudi Vascular, Inc.. Products Portfolio

Table 48: MicroVention, Inc. Basic Information And Sales Area

Table 49: MicroVention, Inc.. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global open surgery heart valves Market Value (USD Million) By Region

Table 55: Global open surgery heart valves Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

open surgery heart valves Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott Vascular Inc.; Arterius Ltd; Cardionovum GmbH; Aneuclose LLC; InspireMD, Inc.; Tepha, Inc.; Boston Scientific Corporation; Japan Stent Technology Co.,Ltd.; Gaudi Vascular, Inc.; MicroVention, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options